Hypergammaglobulinemia natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
****Disseminated | ****Disseminated | ||
****Opportunistic Pneumocystis jirovecii pneumonia infections | ****Opportunistic Pneumocystis jirovecii pneumonia infections | ||
**Gastrointestinal tumors | **Gastrointestinal tumors (carcinoid of pancreas, glucagonoma of pancreas) | ||
*Life-threatening complications in adolescents and young adults with x-linked hyper-Ig M include:<ref>Johnson J, Filipovich AH, Zhang K. X-Linked Hyper IgM Syndrome. 2007 May 31 [Updated 2013 Jan 24]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1402/</ref> | |||
**Liver disease | |||
***Primary cirrhosis | |||
***Carcinomas (bile duct carcinoma, hepatocellular carcinoma, adenocarcinomas of the liver and gall bladder) | |||
*The activation-induced cysteine deaminase (AICDA) deficient patients are at an increased risk of developing inflammatory as well as autoimmune diseases like chronic arthritis, autoimmune hemolytic anemia, and autoimmune thrombocytopenia.<ref name="pmid14962793">{{cite journal| author=Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A et al.| title=Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. | journal=Clin Immunol | year= 2004 | volume= 110 | issue= 1 | pages= 22-9 | pmid=14962793 | doi=10.1016/j.clim.2003.10.007 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14962793 }} </ref> | *The activation-induced cysteine deaminase (AICDA) deficient patients are at an increased risk of developing inflammatory as well as autoimmune diseases like chronic arthritis, autoimmune hemolytic anemia, and autoimmune thrombocytopenia.<ref name="pmid14962793">{{cite journal| author=Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A et al.| title=Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. | journal=Clin Immunol | year= 2004 | volume= 110 | issue= 1 | pages= 22-9 | pmid=14962793 | doi=10.1016/j.clim.2003.10.007 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14962793 }} </ref> | ||
Revision as of 16:44, 2 March 2016
|
Hypergammaglobulinemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypergammaglobulinemia natural history On the Web |
|
American Roentgen Ray Society Images of Hypergammaglobulinemia natural history |
|
Risk calculators and risk factors for Hypergammaglobulinemia natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Natural History
Complications
- Common complications of x-linked hyper-Ig M include:[1]
- Infection
- Viral
- Disseminated cytomegalovirus and herpes simplex virus infections
- Bacterial
- Cholangitis from Cryptosporidium parvum
- Fungal
- Disseminated
- Opportunistic Pneumocystis jirovecii pneumonia infections
- Viral
- Gastrointestinal tumors (carcinoid of pancreas, glucagonoma of pancreas)
- Infection
- Life-threatening complications in adolescents and young adults with x-linked hyper-Ig M include:[2]
- Liver disease
- Primary cirrhosis
- Carcinomas (bile duct carcinoma, hepatocellular carcinoma, adenocarcinomas of the liver and gall bladder)
- Liver disease
- The activation-induced cysteine deaminase (AICDA) deficient patients are at an increased risk of developing inflammatory as well as autoimmune diseases like chronic arthritis, autoimmune hemolytic anemia, and autoimmune thrombocytopenia.[3]
Prognosis
References
- ↑ Fried AJ, Bonilla FA (2009). "Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections". Clin Microbiol Rev. 22 (3): 396–414. doi:10.1128/CMR.00001-09. PMC 2708392. PMID 19597006.
- ↑ Johnson J, Filipovich AH, Zhang K. X-Linked Hyper IgM Syndrome. 2007 May 31 [Updated 2013 Jan 24]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1402/
- ↑ Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A; et al. (2004). "Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency". Clin Immunol. 110 (1): 22–9. doi:10.1016/j.clim.2003.10.007. PMID 14962793.